Bristol-Myers Squibb Co. (BMY) Financials Nov 18,
Post# of 250602
Posted On: 11/18/2014 9:50:07 PM
Bristol-Myers Squibb Co. (BMY) Financials Nov 18, 2014, 4:20 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Bristol-Myers Squibb Co.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 18.81B 19.48B 21.24B 17.62B 16.39B
Cost of Goods Sold (COGS) incl. D&A 5.03B 5.15B 5.52B 4.46B 4.53B
COGS excluding D&A 4.32B 4.41B 4.72B 3.78B 3.22B
Depreciation & Amortization Expense 707M 744M 801M 681M 1.31B
Depreciation 469M 473M 448M 382M 453M
Amortization of Intangibles 238M 271M 353M 299M 858M
Gross Income 13.78B 14.33B 15.72B 13.16B 11.86B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 8.73B 8.19B 8.94B 8.92B 8.65B
Research & Development 3.65B 3.57B 3.81B 3.9B 3.73B
Other SG&A 5.08B 4.63B 5.13B 5.02B 4.92B
Other Operating Expense 0 0 0 0 0
Unusual Expense 225M 620M 223M 2.3B 298M
EBIT after Unusual Expense (225M) (620M) (223M) (2.3B) (298M)
Non Operating Income/Expense 477M 440M 198M 404M (86M)
Non-Operating Interest Income 54M 75M 91M 0 104M
Equity in Affiliates (Pretax) 550M 313M 281M 183M 166M
Interest Expense 302M 273M 145M 182M 199M
Gross Interest Expense 315M 281M 145M 182M 199M
Interest Capitalized 13M 8M 0 0 0
Pretax Income 5.6B 6.07B 6.98B 2.34B 2.89B
Income Tax 1.18B 1.56B 1.72B (161M) 311M
Income Tax - Current Domestic 410M 797M 864M 627M 375M
Income Tax - Current Foreign 646M 339M 442M 442M 427M
Income Tax - Deferred Domestic 126M 438M 406M (1.16B) (390M)
Income Tax - Deferred Foreign - (16M) 9M (66M) (101M)
Income Tax Credits - - - - -
Equity in Affiliates - - - - -
Other After Tax Income (Expense) 0 (12M) 0 (1M) 0
Consolidated Net Income 4.42B 4.5B 5.26B 2.5B 2.58B
Minority Interest Expense 1.25B 1.41B 1.55B 541M 17M
Net Income 3.17B 3.09B 3.71B 1.96B 2.56B
Extraordinaries & Discontinued Operations 7.44B 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 7.16B 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 285M 0 0 0 0
Net Income After Extraordinaries 10.61B 3.09B 3.71B 1.96B 2.56B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 3.17B 3.09B 3.71B 1.96B 2.56B
EPS (Basic) 1.75 1.80 2.18 1.17 1.56
Basic Shares Outstanding 1.97B 1.71B 1.7B 1.67B 1.64B
EPS (Diluted) 1.75 1.79 2.16 1.16 1.54
Diluted Shares Outstanding 1.98B 1.73B 1.72B 1.69B 1.66B
EBITDA 5.76B 6.88B 7.58B 4.92B 4.52B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Bristol-Myers Squibb Co.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 18.81B 19.48B 21.24B 17.62B 16.39B
Cost of Goods Sold (COGS) incl. D&A 5.03B 5.15B 5.52B 4.46B 4.53B
COGS excluding D&A 4.32B 4.41B 4.72B 3.78B 3.22B
Depreciation & Amortization Expense 707M 744M 801M 681M 1.31B
Depreciation 469M 473M 448M 382M 453M
Amortization of Intangibles 238M 271M 353M 299M 858M
Gross Income 13.78B 14.33B 15.72B 13.16B 11.86B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 8.73B 8.19B 8.94B 8.92B 8.65B
Research & Development 3.65B 3.57B 3.81B 3.9B 3.73B
Other SG&A 5.08B 4.63B 5.13B 5.02B 4.92B
Other Operating Expense 0 0 0 0 0
Unusual Expense 225M 620M 223M 2.3B 298M
EBIT after Unusual Expense (225M) (620M) (223M) (2.3B) (298M)
Non Operating Income/Expense 477M 440M 198M 404M (86M)
Non-Operating Interest Income 54M 75M 91M 0 104M
Equity in Affiliates (Pretax) 550M 313M 281M 183M 166M
Interest Expense 302M 273M 145M 182M 199M
Gross Interest Expense 315M 281M 145M 182M 199M
Interest Capitalized 13M 8M 0 0 0
Pretax Income 5.6B 6.07B 6.98B 2.34B 2.89B
Income Tax 1.18B 1.56B 1.72B (161M) 311M
Income Tax - Current Domestic 410M 797M 864M 627M 375M
Income Tax - Current Foreign 646M 339M 442M 442M 427M
Income Tax - Deferred Domestic 126M 438M 406M (1.16B) (390M)
Income Tax - Deferred Foreign - (16M) 9M (66M) (101M)
Income Tax Credits - - - - -
Equity in Affiliates - - - - -
Other After Tax Income (Expense) 0 (12M) 0 (1M) 0
Consolidated Net Income 4.42B 4.5B 5.26B 2.5B 2.58B
Minority Interest Expense 1.25B 1.41B 1.55B 541M 17M
Net Income 3.17B 3.09B 3.71B 1.96B 2.56B
Extraordinaries & Discontinued Operations 7.44B 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 7.16B 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 285M 0 0 0 0
Net Income After Extraordinaries 10.61B 3.09B 3.71B 1.96B 2.56B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 3.17B 3.09B 3.71B 1.96B 2.56B
EPS (Basic) 1.75 1.80 2.18 1.17 1.56
Basic Shares Outstanding 1.97B 1.71B 1.7B 1.67B 1.64B
EPS (Diluted) 1.75 1.79 2.16 1.16 1.54
Diluted Shares Outstanding 1.98B 1.73B 1.72B 1.69B 1.66B
EBITDA 5.76B 6.88B 7.58B 4.92B 4.52B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)Scroll down for more posts ▼